
Board of directors
Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on
Bristol Myers Squibb's Leadership Team , who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.
About us
Leadership
Board of directors
Share Icon
Follow us on LinkedIn
Follow us on Twitter
Follow us on Facebook
Chris Boerner, PhD >
Board Chair and Chief Executive Officer
Theodore R. Samuels >
Lead Independent Director and Retired President of Capital Guardian Trust Company
Peter J. Arduini >
President and Chief Executive Officer of GE Healthcare
Deepak L. Bhatt, MD, MPH  >
Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine
Julia A. Haller, MD >
Ophthalmologist-in-Chief, Wills Eye Hospital
Manuel Hidalgo Medina, MD, PhD >
Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College and Attending Physician, New York-Presbyterian Hospital
Paula A. Price >
Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.
Derica W. Rice >
Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark. Former Executive Vice President and Chief Financial Officer, Eli Lilly Company
Karen H. Vousden, PhD >
Principal Group Leader of The Francis Crick Institute and Former Chief Scientist of Cancer Research UK
Phyllis R. Yale >
Advisory Partner, Bain & Company

June 05, 2024
© 2024
Bristol-Myers Squibb Company